Back
Vanguard Total Stock Market Index Fund ETF Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison
Buy
73
VTI
Vanguard Total Stock Market Index Fund ETF
Last Price:
$336.58
Seasonality Move:
1.33%
Sell
50
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$68.58
Seasonality Move:
40.49%
Buy
73
Vanguard Total Stock Market Index Fund ETF (VTI)
is a Buy
Is Vanguard Total Stock Market Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard Total Stock Market Index Fund ETF [VTI] share price is $336.57. The Score for VTI is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
VTI is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $68.60. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VTI Stock Price Chart
What is Vanguard Total Stock Market Index Fund ETF's stock price today?
-
The Vanguard Total Stock Market Index Fund ETF share price today is $336.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTI is experiencing slight selling pressure.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $68.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.
VTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 64.61 | Buy |
| Relative Strength Index (14 RSI): | 58.16 | Buy |
| Chaikin Money Flow: | -898828 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (327.04 - 336.58) | Buy |
| Bollinger Bands (100): | (315.44 - 332.94) | Buy |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.94 | Buy |
| Relative Strength Index (14 RSI): | 75.92 | Buy |
| Chaikin Money Flow: | 249389 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.15 - 56.87) | Buy |
| Bollinger Bands (100): | (20.01 - 44.73) | Buy |
VTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 336.03 | Buy |
| 20-day SMA: | 331.76 | Buy |
| 50-day SMA: | 331.14 | Buy |
| 200-day SMA: | 304.4 | Buy |
| 8-day EMA: | 332.5 | Buy |
| 20-day EMA: | 283.47 | Buy |
| 50-day EMA: | 176.86 | Buy |
| 200-day EMA: | 57.4 | Buy |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.55 | Buy |
| 20-day SMA: | 48.94 | Buy |
| 50-day SMA: | 42.23 | Buy |
| 200-day SMA: | 23.8 | Buy |
| 8-day EMA: | 60.08 | Buy |
| 20-day EMA: | 52.14 | Buy |
| 50-day EMA: | 43.49 | Buy |
| 200-day EMA: | 29.21 | Buy |
Vanguard Total Stock Market Index Fund ETF Earnings Growth & VTI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.
Vanguard Total Stock Market Index Fund ETF Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||